{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:09:31Z","timestamp":1790770171734,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.prp.2018.02.015","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T07:16:25Z","timestamp":1519197385000},"page":"513-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The degree of overlap between the follicular dendritic cell meshwork and tumor cells in mantle cell lymphoma is associated with prognosis"],"prefix":"10.1016","volume":"214","author":[{"given":"Weihua","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoge","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2018.02.015_bib0005","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"229","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.prp.2018.02.015_bib0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","article-title":"Mantle cell lymphoma\u2013a spectrum from indolent to aggressive disease","volume":"468","author":"Sander","year":"2016","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2018.02.015_bib0015","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.24797","article-title":"Mantle cell lymphoma: 2017 update on diagnosis risk-stratification, and clinical management","volume":"92","author":"Vose","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.prp.2018.02.015_bib0020","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2018.02.015_bib0025","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1080\/10428194.2016.1248965","article-title":"The molecular pathogenesis of mantle cell lymphoma","volume":"58","author":"Vogt","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2018.02.015_bib0030","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3109\/10428194.2014.940584","article-title":"Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network","volume":"56","author":"Dreyling","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2018.02.015_bib0035","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"285","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.prp.2018.02.015_bib0040","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/10428194.2013.815349","article-title":"Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database","volume":"55","author":"Salek","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2018.02.015_bib0045","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2018.02.015_bib0050","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/cncr.30068","article-title":"Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma","volume":"122","author":"Cohen","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2018.02.015_bib0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11899-016-0324-3","article-title":"Which patients with mantle cell lymphoma do not need aggressive therapy","volume":"11","author":"Ruan","year":"2016","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.prp.2018.02.015_bib0060","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","article-title":"Outcome of deferred initial therapy in mantle-cell lymphoma","volume":"27","author":"Martin","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2018.02.015_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hemonc.2017.02.003","article-title":"Mantle cell lymphoma: contemporary diagnostic and treatment perspectives in the age of personalized medicine","volume":"10","author":"Sandoval-Sus","year":"2017","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"10.1016\/j.prp.2018.02.015_bib0070","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the european mantle cell lymphoma network","volume":"34","author":"Hoster","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2018.02.015_bib0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.prp.2018.02.015_bib0080","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2013.52.2466","article-title":"Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network","volume":"32","author":"Hoster","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2018.02.015_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5045\/br.2016.51.2.127","article-title":"Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma","volume":"51","author":"Jeong","year":"2016","journal-title":"Blood Res."},{"key":"10.1016\/j.prp.2018.02.015_bib0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00428-005-0049-5","article-title":"Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients","volume":"448","author":"Schrader","year":"2006","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2018.02.015_bib0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/ajcp\/101.6.761","article-title":"Follicular dendritic cells have prognostic relevance in Hodgkin's disease","volume":"101","author":"Alavaikko","year":"1994","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2018.02.015_bib0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2559.1998.t01-1-00418.x","article-title":"Prognostic value of follicular dendritic cells in nodular sclerosing Hodgkin's disease","volume":"32","author":"Baur","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2018.02.015_bib0105","first-page":"96","article-title":"Immunohistochemical detection of follicular dendritic cells in the diagnosis of small B-cell lymphomas","volume":"39","author":"Fakan","year":"2003","journal-title":"Cesk. Patol."},{"key":"10.1016\/j.prp.2018.02.015_bib0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/PAP.0000000000000030","article-title":"Follicular dendritic cell pattern in early lymphomas involving follicles","volume":"21","author":"Carbone","year":"2014","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2018.02.015_bib0115","first-page":"222","article-title":"Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas","volume":"42","author":"Shi","year":"2013","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.prp.2018.02.015_bib0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.humpath.2012.10.005","article-title":"Follicular dendritic cells: origin function, and different disease-associated patterns","volume":"44","author":"Rezk","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2018.02.015_bib0125","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2559.2011.03779.x","article-title":"Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome","volume":"58","author":"Jin","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2018.02.015_bib0130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1440-1827.2011.02736.x","article-title":"Nodal follicular lymphoma without complete follicular dendritic cell networks is related to localized clinical stage","volume":"61","author":"Cui","year":"2011","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2018.02.015_bib0135","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/modpathol.2009.51","article-title":"Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations","volume":"22","author":"Takata","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2018.02.015_bib0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/annonc\/mdp495","article-title":"Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma","volume":"21","author":"Schaffel","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2018.02.015_bib0145","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1002\/cncr.28219","article-title":"Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission","volume":"119","author":"Chakhachiro","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2018.02.015_bib0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/his.12624","article-title":"Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma","volume":"67","author":"Blaker","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2018.02.015_bib0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","article-title":"Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network","volume":"2","author":"Klapper","year":"2009","journal-title":"J. Hematop."},{"key":"10.1016\/j.prp.2018.02.015_bib0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10428199409051675","article-title":"Follicular dendritic cells in non-Hodgkin's lymphomas","volume":"15","author":"Petrasch","year":"1994","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2018.02.015_bib0165","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2010-03-275925","article-title":"Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a","volume":"116","author":"Lwin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.prp.2018.02.015_bib0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2007.12.001","article-title":"Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function","volume":"20","author":"Allen","year":"2008","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.prp.2018.02.015_bib0175","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1172\/JCI64210","article-title":"A microenvironment-mediated c-Myc\/miR-548m\/HDAC6 amplification loop in non-Hodgkin B cell lymphomas","volume":"123","author":"Lwin","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2018.02.015_bib0180","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.semcancer.2011.09.007","article-title":"The complex landscape of genetic alterations in mantle cell lymphoma","volume":"21","author":"Royo","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.prp.2018.02.015_bib0185","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.anndiagpath.2014.03.006","article-title":"Progressive leukemic non-nodal mantle cell lymphoma associated with deletions of TP53 ATM, and\/or 13q14","volume":"18","author":"Chapman-Fredricks","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2018.02.015_bib0190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PAS.0000000000000758","article-title":"Mantle cell lymphoma with MYC rearrangement: a report of 17 patients","volume":"41","author":"Hu","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2018.02.015_bib0195","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2018.02.015_bib0200","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1470-2045(14)70027-0","article-title":"Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial","volume":"15","author":"Ardeshna","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2018.02.015_bib0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2967\/jnumed.116.173542","article-title":"18F-FDG PET for measurement of response and prediction of outcome to relapsed or refractory mantle cell lymphoma therapy with Bendamustine-Rituximab","volume":"58","author":"Lamonica","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.prp.2018.02.015_bib0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejrad.2015.12.006","article-title":"Comparison between whole-body MRI with diffusion-weighted imaging and PET\/CT in staging newly diagnosed FDG-avid lymphomas","volume":"85","author":"Albano","year":"2016","journal-title":"Eur. J. Radiol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817310002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817310002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T23:50:08Z","timestamp":1535068208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817310002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0344033817310002"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2018.02.015","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The degree of overlap between the follicular dendritic cell meshwork and tumor cells in mantle cell lymphoma is associated with prognosis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2018.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}